Sticares InterACT, an internationally operating contract service provider specializing in cardiovascular and metabolic diseases, has been awarded the French research tax credit approval, which it has been holding since 2009. This approval has now been extended for the years 2013, 2014 and 2015.

The French ministry will grant refunds for any French R&D company that spends on services from the approved organization. The research tax credit is either deducted from annual corporate tax, or reimbursed and is calculated on the basis of the amount of R&D expenditure by the company in France.